U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 959 books (19493 items)

1.
Diabetes in America. 3rd edition.

Diabetes in America. 3rd edition.

Cowie CC, Casagrande SS, Menke A, et al., editors.

Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (US); 2018 Aug.

2.
Fabry Disease: Perspectives from 5 Years of FOS.

Fabry Disease: Perspectives from 5 Years of FOS.

Mehta A, Beck M, Sunder-Plassmann G, editors.

Oxford: Oxford PharmaGenesis; 2006.

3.
DNA Mismatch Repair Deficiency Tumour Testing for Patients With Colorectal Cancer: A Health Technology Assessment [Internet].

DNA Mismatch Repair Deficiency Tumour Testing for Patients With Colorectal Cancer: A Health Technology Assessment [Internet].

Assasi N, Blackhouse G, Campbell K, et al.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Aug. (CADTH Optimal Use Report, No. 5.3b.)

4.
Coeliac Disease: Recognition, Assessment and Management.

Coeliac Disease: Recognition, Assessment and Management.

London: National Institute for Health and Care Excellence (NICE); 2015 Sep. (NICE Guideline, No. 20.)

5.
New Drugs for Type 2 Diabetes: Second-Line Therapy — Science Report [Internet].

New Drugs for Type 2 Diabetes: Second-Line Therapy — Science Report [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Sep. (CADTH Therapeutic Review, No. 4.1b.)

6.
Diabetes Medications for Adults With Type 2 Diabetes: An Update [Internet].

Diabetes Medications for Adults With Type 2 Diabetes: An Update [Internet].

Bolen S, Tseng E, Hutfless S, et al.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Apr. (Comparative Effectiveness Reviews, No. 173.)

7.
8.
Evaluating Obesity Prevention Efforts: A Plan for Measuring Progress.

Evaluating Obesity Prevention Efforts: A Plan for Measuring Progress.

Committee on Evaluating Progress of Obesity Prevention Effort; Food and Nutrition Board; Institute of Medicine; Green LW, Sim L, Breiner H, editors.

Washington (DC): National Academies Press (US); 2013 Dec 11.

9.
Bridging the Evidence Gap in Obesity Prevention: A Framework to Inform Decision Making.

Bridging the Evidence Gap in Obesity Prevention: A Framework to Inform Decision Making.

Institute of Medicine (US) Committee on an Evidence Framework for Obesity Prevention Decision Making; Kumanyika SK, Parker L, Sim LJ, editors.

Washington (DC): National Academies Press (US); 2010.

10.
Bone Health and Osteoporosis: A Report of the Surgeon General.

Bone Health and Osteoporosis: A Report of the Surgeon General.

Office of the Surgeon General (US).

Rockville (MD): Office of the Surgeon General (US); 2004.

11.
12.
Exploratory Brief on Glucose Monitoring Technologies [Internet].

Exploratory Brief on Glucose Monitoring Technologies [Internet].

Corabian P, Chojecki D.

Edmonton (AB): Institute of Health Economics; 2017 Jan.

13.
Energy Balance and Obesity.

Energy Balance and Obesity.

Romieu I, Dossus L, Willett WC, editors.

Lyon (FR): International Agency for Research on Cancer; 2017. (IARC Working Group Reports, No. 10.)

14.
Glycerol Phenylbutyrate (Ravicti) [Internet].

Glycerol Phenylbutyrate (Ravicti) [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Apr.

15.
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report.

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report.

NHLBI Obesity Education Initiative Expert Panel on the Identification, Evaluation, and Treatment of Obesity in Adults (US).

Bethesda (MD): National Heart, Lung, and Blood Institute; 1998 Sep.

16.
Canagliflozin (Invokana) for Type 2 Diabetes Mellitus [Internet].

Canagliflozin (Invokana) for Type 2 Diabetes Mellitus [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Sep.

17.
Alogliptin (Nesina) for Type 2 Diabetes Mellitus [Internet].

Alogliptin (Nesina) for Type 2 Diabetes Mellitus [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Aug.

19.
Preventing Childhood Obesity: Health in the Balance.

Preventing Childhood Obesity: Health in the Balance.

Institute of Medicine (US) Committee on Prevention of Obesity in Children and Youth; Koplan JP, Liverman CT, Kraak VI, editors.

Washington (DC): National Academies Press (US); 2005.

20.
Fluid Replacement and Heat Stress.

Fluid Replacement and Heat Stress.

Institute of Medicine (US) Committee on Military Nutrition Research; Marriott BM, editor.

Washington (DC): National Academies Press (US); 1994.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...